IGXT
Price:
$0.17
Market Cap:
$29.69M
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also devel...[Read more]
Industry
Biotechnology
IPO Date
2007-01-17
Stock Exchange
PNK
Ticker
IGXT
According to IntelGenx Technologies Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -2.83. This represents a change of -0.42% compared to the average of -2.84 of the last 4 quarters.
The mean historical PE Ratio of IntelGenx Technologies Corp. over the last ten years is -7.36. The current -2.83 PE Ratio has changed 3.74% with respect to the historical average. Over the past ten years (40 quarters), IGXT's PE Ratio was at its highest in in the September 2016 quarter at 400.01. The PE Ratio was at its lowest in in the March 2015 quarter at -188.05.
Average
-7.36
Median
-3.83
Minimum
-42.28
Maximum
25.59
Discovering the peaks and valleys of IntelGenx Technologies Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.07%
Maximum Annual PE Ratio = 25.59
Minimum Annual Increase = -265.23%
Minimum Annual PE Ratio = -42.28
Year | PE Ratio | Change |
---|---|---|
2023 | -2.43 | -10.53% |
2022 | -2.72 | -48.72% |
2021 | -5.30 | 83.07% |
2020 | -2.89 | -21.89% |
2019 | -3.70 | -6.46% |
2018 | -3.96 | -76.88% |
2017 | -17.13 | -59.48% |
2016 | -42.28 | -265.23% |
2015 | 25.59 | -235.98% |
2014 | -18.82 | 1.94% |
The current PE Ratio of IntelGenx Technologies Corp. (IGXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.48
5-year avg
-3.41
10-year avg
-7.36
IntelGenx Technologies Corp.’s PE Ratio is less than Adynxx, Inc. (0), less than NLS Pharmaceutics AG (0), greater than Ascletis Pharma Inc. (-70.51), greater than Sirona Biochem Corp. (-4.99), greater than LianBio (-7.55), less than Fennec Pharmaceuticals Inc. (0), less than Larimar Therapeutics, Inc. (-0.75), greater than Verrica Pharmaceuticals Inc. (-120.74), greater than Homology Medicines, Inc. (-6.07), less than Candel Therapeutics, Inc. (-0.55), less than PMV Pharmaceuticals, Inc. (-0.01), greater than Acurx Pharmaceuticals, Inc. (-3.09), less than Monopar Therapeutics Inc. (-1.61), less than Enochian Biosciences, Inc. (-0.01), less than Connect Biopharma Holdings Limited (-0.54), less than Acumen Pharmaceuticals, Inc. (-1.00), less than Eton Pharmaceuticals, Inc. (7.24), less than Nuvation Bio Inc. (-1.74), greater than Eledon Pharmaceuticals, Inc. (-53.07), less than null (-1.44), less than null (17.15),
Company | PE Ratio | Market cap |
---|---|---|
0 | $581.00 | |
0 | $8.19M | |
-70.51 | $172.62M | |
-4.99 | $14.63M | |
-7.55 | $34.47M | |
0 | $145.92M | |
-0.75 | $393.05M | |
-120.74 | $45.35M | |
-6.07 | $3.02M | |
-0.55 | $163.68M | |
-0.01 | $83.31M | |
-3.09 | $22.80M | |
-1.61 | $106.08M | |
-0.01 | $45.38M | |
-0.54 | $55.25M | |
-1.00 | $142.39M | |
7.24 | $290.14M | |
-1.74 | $942.39M | |
-53.07 | $239.55M | |
-1.44 | $0 | |
17.15 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntelGenx Technologies Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IntelGenx Technologies Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is IntelGenx Technologies Corp.'s PE Ratio?
How is the PE Ratio calculated for IntelGenx Technologies Corp. (IGXT)?
What is the highest PE Ratio for IntelGenx Technologies Corp. (IGXT)?
What is the 3-year average PE Ratio for IntelGenx Technologies Corp. (IGXT)?
What is the 5-year average PE Ratio for IntelGenx Technologies Corp. (IGXT)?
How does the current PE Ratio for IntelGenx Technologies Corp. (IGXT) compare to its historical average?